Surgical Science Sweden AB (publ) (SUS.ST)

SEK 108.6

(-6.54%)

Revenue Summary of Surgical Science Sweden AB (publ)

Surgical Science Sweden AB (publ)'s latest annual revenue in 2023 was 882.85 Million SEK , up 10.01% from previous year.
Surgical Science Sweden AB (publ)'s latest quarterly revenue in 2024 Q2 was 212.46 Million SEK , up 12.87% from previous quarter.
Surgical Science Sweden AB (publ) reported a annual revenue of 802.54 Million SEK in annual revenue 2022, up 118.81% from previous year.
Surgical Science Sweden AB (publ) reported a annual revenue of 366.77 Million SEK in annual revenue 2021, up 249.98% from previous year.
Surgical Science Sweden AB (publ) reported a quarterly revenue of 212.46 Million SEK for 2024 Q2, up 12.87% from previous quarter.
Surgical Science Sweden AB (publ) reported a quarterly revenue of 210.24 Million SEK for 2023 Q3, down -2.77% from previous quarter.

Annual Revenue Chart of Surgical Science Sweden AB (publ) (2023 - 2014)

Historical Annual Revenue of Surgical Science Sweden AB (publ) (2023 - 2014)

Year	Revenue	Revenue Growth
2023	882.85 Million SEK	10.01%
2022	802.54 Million SEK	118.81%
2021	366.77 Million SEK	249.98%
2020	104.79 Million SEK	3.23%
2019	101.51 Million SEK	54.51%
2018	65.7 Million SEK	13.32%
2017	57.97 Million SEK	11.92%
2016	51.8 Million SEK	12.36%
2015	46.1 Million SEK	12.16%
2014	41.1 Million SEK	0.0%

Year	Revenue	Revenue Growth
2024 Q1	188.24 Million SEK	-17.18%
2024 Q2	212.46 Million SEK	12.87%
2023 Q3	210.24 Million SEK	-2.77%
2023 FY	882.85 Million SEK	10.01%
2023 Q1	229.07 Million SEK	-8.41%
2023 Q2	216.23 Million SEK	-5.61%
2023 Q4	227.29 Million SEK	8.11%
2022 Q1	159.13 Million SEK	-19.5%
2022 FY	802.54 Million SEK	118.81%
2022 Q4	250.1 Million SEK	21.96%
2022 Q3	205.07 Million SEK	8.96%
2022 Q2	188.21 Million SEK	18.27%
2021 Q2	36.56 Million SEK	-1.72%
2021 Q1	37.2 Million SEK	-6.04%
2021 FY	366.77 Million SEK	249.98%
2021 Q4	197.69 Million SEK	107.4%
2021 Q3	95.31 Million SEK	160.71%
2020 Q1	19.65 Million SEK	-49.93%
2020 Q3	24.92 Million SEK	20.89%
2020 Q4	39.59 Million SEK	58.83%
2020 FY	104.79 Million SEK	3.23%
2020 Q2	20.62 Million SEK	4.92%
2019 Q1	13.82 Million SEK	-45.56%
2019 FY	101.51 Million SEK	54.51%
2019 Q3	32.29 Million SEK	100.09%
2019 Q4	39.25 Million SEK	21.55%
2019 Q2	16.14 Million SEK	16.73%
2018 Q2	14.9 Million SEK	30.7%
2018 FY	65.7 Million SEK	13.32%
2018 Q3	13.8 Million SEK	-7.38%
2018 Q4	25.4 Million SEK	84.06%
2018 Q1	11.4 Million SEK	-53.8%
2017 Q4	24.67 Million SEK	141.92%
2017 Q1	11.1 Million SEK	-57.63%
2017 FY	57.97 Million SEK	11.92%
2017 Q2	12 Million SEK	8.11%
2017 Q3	10.2 Million SEK	-15.0%
2016 Q2	10.2 Million SEK	-1.92%
2016 Q1	10.4 Million SEK	0.0%
2016 Q3	5 Million SEK	-50.98%
2016 FY	51.8 Million SEK	12.36%
2016 Q4	26.2 Million SEK	424.0%
2015 FY	46.1 Million SEK	12.16%
2014 FY	41.1 Million SEK	0.0%

Peer Revenue Comparison of Surgical Science Sweden AB (publ)

Name	Revenue	Revenue Difference
Aino Health AB (publ)	23.91 Million SEK	-3591.011%
Bonzun AB (publ)	2.73 Million SEK	-32168.184%
Kontigo Care AB (publ)	28.94 Million SEK	-2949.789%
Medhelp Care Aktiebolag (publ)	84.08 Million SEK	-949.978%
RaySearch Laboratories AB (publ)	1.02 Billion SEK	13.629%